Cargando…
Safety of transradial and transfemoral left ventricular compared with transfemoral right ventricular endomyocardial biopsy
AIMS: With the present study, we sought to determine the safety of three different endomyocardial biopsy (EMB) access routes in 514 patients admitted for diagnostic workup of heart failure of unknown aetiology. METHODS AND RESULTS: In this retrospective monocentric cohort study, we analysed 514 cons...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754772/ https://www.ncbi.nlm.nih.gov/pubmed/32949187 http://dx.doi.org/10.1002/ehf2.13006 |
_version_ | 1783626259019857920 |
---|---|
author | Göbel, Sebastian Schwuchow‐Thonke, Sören Jansen, Thomas Karbach, Susanne Emrich, Tilman Gori, Tommaso Knies, Finja Schulz, Eberhard Münzel, Thomas Keller, Karsten Wenzel, Philip |
author_facet | Göbel, Sebastian Schwuchow‐Thonke, Sören Jansen, Thomas Karbach, Susanne Emrich, Tilman Gori, Tommaso Knies, Finja Schulz, Eberhard Münzel, Thomas Keller, Karsten Wenzel, Philip |
author_sort | Göbel, Sebastian |
collection | PubMed |
description | AIMS: With the present study, we sought to determine the safety of three different endomyocardial biopsy (EMB) access routes in 514 patients admitted for diagnostic workup of heart failure of unknown aetiology. METHODS AND RESULTS: In this retrospective monocentric cohort study, we analysed 514 consecutive patients with heart failure without evidence of significant coronary artery disease or valvular disease undergoing EMB between November 2013 and December 2018, stratified in three access route groups: transradial arterial left ventricular (LV‐)EMB (323 patients), transfemoral LV‐EMB (138 patients), and transfemoral right ventricular (RV‐)EMB (53 patients). Patients undergoing selective transradial LV‐EMB were older compared with patients undergoing selective transfemoral LV‐EMB or RV‐EMB [transradial LV‐EMB: 56.0 (45.0/64.0) vs. transfemoral LV‐EMB: 53 (42.5/64.5), P = 0.455; transradial LV‐EMB: 56 (45.0/64.0) vs. RV‐EMB: 53 (42.5/64), P = 0.695] and presented more often in New York Heart Association‐functional class III and IV. A total of eight major complications including permanent atrioventricular block requiring pacemaker implantation, pericardial tamponade necessitating pericardiocentesis, stroke and transient cerebral ischaemic attack as well as severe valvular damage, vascular access site complications, and ventricular fibrillation were documented with no significant differences between the groups (8/514, 1.5%). Minor complications such as transient chest pain, non‐sustained electrocardiogram abnormalities, and transient atrioventricular block were rare and equally distributed between groups. CONCLUSIONS: Transradial LV‐EMB is a safe procedure for experienced radial operators and non‐inferior compared with transfemoral LV‐EMB and RV‐EMB. An accurate peri‐procedural and post‐procedural monitoring and follow‐up care should be recommended for all patients undergoing this procedure in order to identify potential complications. |
format | Online Article Text |
id | pubmed-7754772 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77547722020-12-23 Safety of transradial and transfemoral left ventricular compared with transfemoral right ventricular endomyocardial biopsy Göbel, Sebastian Schwuchow‐Thonke, Sören Jansen, Thomas Karbach, Susanne Emrich, Tilman Gori, Tommaso Knies, Finja Schulz, Eberhard Münzel, Thomas Keller, Karsten Wenzel, Philip ESC Heart Fail Original Research Articles AIMS: With the present study, we sought to determine the safety of three different endomyocardial biopsy (EMB) access routes in 514 patients admitted for diagnostic workup of heart failure of unknown aetiology. METHODS AND RESULTS: In this retrospective monocentric cohort study, we analysed 514 consecutive patients with heart failure without evidence of significant coronary artery disease or valvular disease undergoing EMB between November 2013 and December 2018, stratified in three access route groups: transradial arterial left ventricular (LV‐)EMB (323 patients), transfemoral LV‐EMB (138 patients), and transfemoral right ventricular (RV‐)EMB (53 patients). Patients undergoing selective transradial LV‐EMB were older compared with patients undergoing selective transfemoral LV‐EMB or RV‐EMB [transradial LV‐EMB: 56.0 (45.0/64.0) vs. transfemoral LV‐EMB: 53 (42.5/64.5), P = 0.455; transradial LV‐EMB: 56 (45.0/64.0) vs. RV‐EMB: 53 (42.5/64), P = 0.695] and presented more often in New York Heart Association‐functional class III and IV. A total of eight major complications including permanent atrioventricular block requiring pacemaker implantation, pericardial tamponade necessitating pericardiocentesis, stroke and transient cerebral ischaemic attack as well as severe valvular damage, vascular access site complications, and ventricular fibrillation were documented with no significant differences between the groups (8/514, 1.5%). Minor complications such as transient chest pain, non‐sustained electrocardiogram abnormalities, and transient atrioventricular block were rare and equally distributed between groups. CONCLUSIONS: Transradial LV‐EMB is a safe procedure for experienced radial operators and non‐inferior compared with transfemoral LV‐EMB and RV‐EMB. An accurate peri‐procedural and post‐procedural monitoring and follow‐up care should be recommended for all patients undergoing this procedure in order to identify potential complications. John Wiley and Sons Inc. 2020-09-19 /pmc/articles/PMC7754772/ /pubmed/32949187 http://dx.doi.org/10.1002/ehf2.13006 Text en © 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Research Articles Göbel, Sebastian Schwuchow‐Thonke, Sören Jansen, Thomas Karbach, Susanne Emrich, Tilman Gori, Tommaso Knies, Finja Schulz, Eberhard Münzel, Thomas Keller, Karsten Wenzel, Philip Safety of transradial and transfemoral left ventricular compared with transfemoral right ventricular endomyocardial biopsy |
title | Safety of transradial and transfemoral left ventricular compared with transfemoral right ventricular endomyocardial biopsy |
title_full | Safety of transradial and transfemoral left ventricular compared with transfemoral right ventricular endomyocardial biopsy |
title_fullStr | Safety of transradial and transfemoral left ventricular compared with transfemoral right ventricular endomyocardial biopsy |
title_full_unstemmed | Safety of transradial and transfemoral left ventricular compared with transfemoral right ventricular endomyocardial biopsy |
title_short | Safety of transradial and transfemoral left ventricular compared with transfemoral right ventricular endomyocardial biopsy |
title_sort | safety of transradial and transfemoral left ventricular compared with transfemoral right ventricular endomyocardial biopsy |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754772/ https://www.ncbi.nlm.nih.gov/pubmed/32949187 http://dx.doi.org/10.1002/ehf2.13006 |
work_keys_str_mv | AT gobelsebastian safetyoftransradialandtransfemoralleftventricularcomparedwithtransfemoralrightventricularendomyocardialbiopsy AT schwuchowthonkesoren safetyoftransradialandtransfemoralleftventricularcomparedwithtransfemoralrightventricularendomyocardialbiopsy AT jansenthomas safetyoftransradialandtransfemoralleftventricularcomparedwithtransfemoralrightventricularendomyocardialbiopsy AT karbachsusanne safetyoftransradialandtransfemoralleftventricularcomparedwithtransfemoralrightventricularendomyocardialbiopsy AT emrichtilman safetyoftransradialandtransfemoralleftventricularcomparedwithtransfemoralrightventricularendomyocardialbiopsy AT goritommaso safetyoftransradialandtransfemoralleftventricularcomparedwithtransfemoralrightventricularendomyocardialbiopsy AT kniesfinja safetyoftransradialandtransfemoralleftventricularcomparedwithtransfemoralrightventricularendomyocardialbiopsy AT schulzeberhard safetyoftransradialandtransfemoralleftventricularcomparedwithtransfemoralrightventricularendomyocardialbiopsy AT munzelthomas safetyoftransradialandtransfemoralleftventricularcomparedwithtransfemoralrightventricularendomyocardialbiopsy AT kellerkarsten safetyoftransradialandtransfemoralleftventricularcomparedwithtransfemoralrightventricularendomyocardialbiopsy AT wenzelphilip safetyoftransradialandtransfemoralleftventricularcomparedwithtransfemoralrightventricularendomyocardialbiopsy |